1-eicosanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Metabolite details

Identifier

WAFWSBFKIPCFOF-ZDAJSWCOSA-N

InChI Key

WAFWSBFKIPCFOF-ZDAJSWCOSA-N

IUPAC name

(2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(icosanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1-eicosanoyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

INN name

—

Synonym

PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

ChEBI

CHEBI:86221

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• Flow cytometry has a significant impact on the cellular metabolome (General LC-MS assay)
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_Plasma_vs_WY-14,643_Plasma
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Wild_Type_vs_TMAVA_Treatment
• Control_12h_vs_Toxocara canis_12h
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_Palmitate
• Ctrl_vs_Ab
• BSA_Control_vs_AA